Literature DB >> 30844311

Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.

Wei Wang1, Tatsuma Hind1,2, Brenda Wan Shing Lam1, Deron R Herr1,3.   

Abstract

Epithelial-mesenchymal transition (EMT) is a critical process implicated in the initial stage of cancer metastasis, which is the major cause of tumor recurrence and mortality. Although key transcription factors that regulate EMT, such as snail family transcriptional repressor 2 (SNAI2), are well characterized, the upstream signaling pathways controlling these transcriptional mediators are largely unknown, which limits therapeutic strategies. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator, generated by sphingosine kinases (SPHK1 and SPHK2), that mainly exerts its effects by binding to the following 5 GPCRs: S1P1 to S1P5. S1P signaling has been reported to regulate different aspects of cancer progression including cell proliferation, apoptosis, and migration; nevertheless, its role in cancer metastasis, specifically via EMT, is not established. Here we show that SPHK1 expression correlates significantly with EMT score in breast cancer cell lines, and with SNAI2 in patient-derived breast tumors. Cell-based assays demonstrate that S1P can rapidly up-regulate the expression of SNAI2 in breast cancer cells via the activation of cognate receptors S1P2 and S1P3. Knockdown studies suggest that S1P2 and S1P3 mediate this effect by activating myocardin-related transcription factor A (MRTF-A) and yes-associated protein (YAP), respectively. Michigan Cancer Foundation 7 cells stably overexpressing S1P2 or S1P3 exhibit a more invasive phenotype, when compared to control cells. Taken together, our findings suggest that S1P produced by SPHK1 induces SNAI2 expression via S1P2-YAP and S1P3-MRTF-A pathways, leading to enhanced cell invasion. Cumulatively, this study reveals a novel mechanism by which S1P activates parallel pathways that regulate the expression of SNAI2, a master regulator of EMT, and provides new insights into druggable therapeutic targets that may limit cancer metastasis. Wang, W., Hind, T., Lam, B. W. S., Herr, D. R. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.

Entities:  

Keywords:  EMT; MRTF-A; SPHK1; YAP; epithelial-mesenchymal transition

Mesh:

Substances:

Year:  2019        PMID: 30844311     DOI: 10.1096/fj.201801635R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.

Authors:  Ronald T Riley; Alfred H Merrill
Journal:  J Lipid Res       Date:  2019-05-02       Impact factor: 5.922

2.  Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.

Authors:  Yongyun Li; Jie Yang; Qianqian Zhang; Shiqiong Xu; Wei Sun; Shengfang Ge; Xiaowei Xu; Martine J Jager; Renbing Jia; Jianming Zhang; Xianqun Fan
Journal:  Oncogene       Date:  2022-06-13       Impact factor: 8.756

Review 3.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

4.  Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.

Authors:  Alison W Ha; Tara Sudhadevi; David L Ebenezer; Panfeng Fu; Evgeny V Berdyshev; Steven J Ackerman; Viswanathan Natarajan; Anantha Harijith
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-22       Impact factor: 5.464

5.  Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy.

Authors:  Wei Wang; Ping Xiang; Wee Siong Chew; Federico Torta; Aishwarya Bandla; Violeta Lopez; Wei Lun Seow; Brenda Wan Shing Lam; Jing Kai Chang; Peiyan Wong; Kanokporn Chayaburakul; Wei-Yi Ong; Markus R Wenk; Raghav Sundar; Deron R Herr
Journal:  J Biol Chem       Date:  2019-12-27       Impact factor: 5.157

Review 6.  Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration.

Authors:  Chiara Sassoli; Federica Pierucci; Sandra Zecchi-Orlandini; Elisabetta Meacci
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

7.  Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.

Authors:  Chao-Qun Wang; Chih-Yang Lin; Yuan-Li Huang; Shih-Wei Wang; Yan Wang; Bi-Fei Huang; Yu-Wei Lai; Shun-Long Weng; Yi-Chin Fong; Chih-Hsin Tang; Zhong Lv
Journal:  Aging (Albany NY)       Date:  2019-12-06       Impact factor: 5.682

8.  Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes.

Authors:  Xiyuan Wu; Meena Kishore Sakharkar; Martin Wabitsch; Jian Yang
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

Review 9.  The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance.

Authors:  Run-Ze Li; Xuan-Run Wang; Jian Wang; Chun Xie; Xing-Xia Wang; Hu-Dan Pan; Wei-Yu Meng; Tu-Liang Liang; Jia-Xin Li; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Elaine Lai-Han Leung
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

Review 10.  Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance.

Authors:  Antonia Piazzesi; Sumaiya Yasmeen Afsar; Gerhild van Echten-Deckert
Journal:  Mol Oncol       Date:  2021-07-29       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.